The efficacy and safety of tyrosine kinase inhibitors in advanced and metastatic thyroid cancer: Study Protocol for a systematic review and meta-analysis of Phase III and IV randomised controlled trials https://www.medrxiv.org/content/10.1101/2023.05.07.23289595